HNN3.0
Register
Register
Register

META Group

Other

www.meta-group.com/Brussels, Belgium
53 profile visits

About

At META Group, we trust in “there is no impact without use”. We believe that a research result or an innovation can generate an outcome and mobilise benefits only after its actual use.

We operate internationally to shape knowledge-based opportunities from idea to start-up and scale-up stages. We are proud of our track record:

  • 10.000+ research and technology organisations supported in exploiting research results

  • 2.000+ research consortia supported in exploiting research results

Specific examples:

  • PHIRE – EIC Transition – Description: bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application in human bladder cancer and effective both in male and female patients. – Website: https://www.phire-project.eu/ - Main partners: Ospedale San Raffaele, University of Bologna, FUJIFILM SONOSITE BV, META Group

  • ECLIPSE – EIC Pathfinder – Description: to design and produce a nanobiotechnological platform for the detection of pathogens (a virus, a bacterium and a protozoan parasite)  that is both economical, usable even by non-expert personnel and with a high level of sensitivity and reliability.  – Website: https://eclipse-project.eu/ - Main partners: University of Bologna, University of Milan, University of Messina, Karlsruher Institut fuer Technologie,  ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI, META Group

Our problem-centered approach, methodologies, and extensive network of experts and partners support scientists and entrepreneurs in laying a strong foundation for sustainable and profitable growth.

Representatives

Innovation Expert

META Group

Marketplace (1)

  • Project cooperation

    We Accelerate Research with our 25+ years of Dissemination & Exploitation Track Recrod

    We help you to bring your research results and IP into use & to market with a shared pains/gains approach.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    Innovation Expert at META Group

    Brussels, Belgium